Concerto HealthAI Names Kevin Cronin as Senior Vice President of Sales and Marketing
A Deeply Experienced Commercial Executive for High-Growth Technology Companies
BOSTON, Oct. 31, 2019 /PRNewswire-PRWeb/ -- Concerto HealthAI announced today that Kevin Cronin has joined the company as Senior Vice President of Sales and Marketing. Kevin brings over 25 years of experience to help advance Concerto HealthAI's mission of making precision oncology a reality with innovative Real-World Data (RWD) products and advanced AI Cloud Technologies that accelerate research and insights at life sciences companies, healthcare providers, and healthcare payers.
Concerto HealthAI is one of the fastest growing startups in the RWD and AI solutions space, with a mission to transform healthcare by revolutionizing clinical and outcomes research, accelerate insights benefitting patients, and bring an array of solutions supporting the entire patient treatment journey. The company is driving needed new innovations with a system of definitive Real-World Data, advanced AI insights, leading outcomes and data science talent, within a state-of-the-art clinical cloud solution.
"Kevin is a values-driven and innovation-focused leader – we will immediately benefit from his decades of experience at rapidly growing technology companies in the life sciences industry" said Jeff Elton, PhD and CEO of Concerto HealthAI. "Kevin brings a set of leadership skills and expertise in growing and managing commercial operations that will accelerate our goals of improving patient outcomes."
Prior to joining Concerto HealthAI, Kevin was the chief commercial officer at Core Informatics for five years. During that time, he oversaw commercialization programs worldwide for the company's innovative SaaS platform. Before Core Informatics, Kevin was global vice president at the BIOVIA brand of Dassault Systemes as well as senior vice president of sales at Symyx Technologies, Inc. Kevin also served as vice president of sales for NextBio and spent 14 years developing and implementing discovery informatics systems for the pharmaceutical industry, first as a research scientist and then as a business leader at MDL Information Systems, a division of Reed Elsevier. Kevin holds a BS in chemistry from the University of Washington.
"I am excited to be joining Concerto HealthAI at such a key point in the company's trajectory," said Kevin Cronin, SVP of Sales and Marketing at Concerto HealthAI. "I look forward to helping the organization grow so that we may continue to advance improvements in clinical outcomes for cancer patients."
# # #
About Concerto HealthAI
Concerto HealthAI is a technology leader in Definitive Real-world Data (RWD) and AI solutions for precision oncology. Our mission is to bring together unique data assets, leading AI-based technologies, and the world's top outcomes research and data science talent. Our focus is on revolutionizing clinical and outcomes research to accelerate the insights benefitting patient treatment. Concerto HealthAI is a SymphonyAI Group company. eurekaHealth is a trademark of Concerto HealthAI. For more information, visit us at http://www.concertohealthai.com.
About SymphonyAI Group
SymphonyAI Group is the fastest-growing private group of B2B AI companies, backed by a $1 billion commitment to deliver next-generation AI solutions for transforming the enterprise. Since its founding in 2017, SymphonyAI Group has grown rapidly to a group of six companies with a combined revenue run rate approaching $300 million. Over 1,600 talented leaders, data scientists, and other professionals operate the group under the leadership of one of Silicon Valley's most successful serial entrepreneurs, Dr. Romesh Wadhwani. Website: http://www.symphonyai.com
Media Contact:
Jennifer Toole
617-779-1828
[email protected]
SOURCE Concerto HealthAI
Share this article